Navigation Links
Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
Date:3/6/2008

nformation about Oncolytics please visit http://www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic; the Company's expectations as to the success of its research and development programs in 2008 and beyond, the Company's planned expansion, the value of the additional patents and intellectual property; the Company's expectations related to the applications of the patented technology; the ability of the technology to strengthen the core technology; the Company's expectations as to adequacy of its existing capital resources; the design, timing, success of planned clinical trial programs and the Company's planned expansion of such programs; and other statements related to anticipated developments in the Company's business and technologies involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statemen
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
3. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
4. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
5. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
6. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial
8. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
9. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
10. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
11. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Launched by the ... in December 2011, ,SARAH, - the French ... versus sorafenib in advanced hepatocellular carcinoma (HCC) has enrolled ... SARAH, a large French study of patients ... HCC) has completed patient enrolment, exceeding its 400-patient target, ...
(Date:3/3/2015)... NASA astronaut Scott Kelly , who is ... a year living and working on the International Space Station, ... 7 a.m. EDT Monday, March 9. Kelly will ... the final weeks of his training. The interviews will be ... highlighting his mission training and previous spaceflights. To ...
(Date:3/3/2015)... , March 3, 2015 /CNW/- SQI Diagnostics Inc. ... commercializes proprietary technologies and products for advanced microarray ... CPA, CA, CFE  to its Management team. In ... Company in its transition from a development stage ... initiatives to advance the Company,s capital market strategy ...
(Date:3/3/2015)... , March 3, 2015 Fried, Frank, ... Jeffrey I.D. Lewis has joined the Firm as ... in the New York office. ... trademark matters, as well as other intellectual property and ... attorney, Mr. Lewis represents both plaintiffs and defendants in ...
Breaking Biology Technology:Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3
... years, most unique must-have gift , ... New York, NY(PRWEB) November 26, ... the customers, DNA, launch DNA Mini Portraits™, a more affordable line of ... Minis are the most personal and unique gifting solution for this holiday ...
... Hearing, a unique manufacturing,and retail company focused on ... professional service, announces the introduction of,assistive listening devices ... are hard of,hearing. The various devices are now ... locations effective November 24, 2008. And, from ...
... MIAMI, Nov. 26 Thomas K. Equels, President and ... to the board of directors,for Hemispherx BioPharma, Inc. (Amex: ... the manufacture and clinical development,of new drug entities for ... Equels, legal practice is ...
Cached Biology Technology:DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season 2Zounds Offers the Gift of Hearing This Holiday Season With a Range of New Products 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3
(Date:2/25/2015)... 2015  ABC Financial Services (ABC), the leading ... and Fitness Industry, today announced enhancements to their ... latest upgrade includes advances to the agreement section ... via Identity One fingerprint biometrics. The features will ... displays at the International Health, Racquet & Sportsclub ...
(Date:2/19/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ) ... Electro-Optical / Infrared Systems Market by Type, by ... to 2020" report to their offering. ... expected to reach $16.35 billion by 2020, to ... report segments the military electro-optical/infrared systems market on ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... Forum article in today,s issue of Science , a ... argued that targets to be met by 2020 under the ... of biodiversity if they are to be attained. ... can be valued by considering the ecosystem services that biodiversity ...
... the inky depths of the Pacific Ocean and 300 ... just made scientific and technological history. The installation of ... observatoryhas been completed. The installation team returned to ... Thompson after four weeks at sea. Most of the ...
... How a T cell decides to make protein X, ... invaders or staving off dire autoimmune reactions. Researchers at the ... that control how different forms of an immune cell protein ... when faced with pathogens, are controlled in the arc of ...
Cached Biology News:NJIT professor helps make case in Science for better biodiversity 2Team completes world-first ocean observatory 2Shifting forms: Penn study shows how variations of same protein affect immune response 2
... Programmable and Digital Orbital Shaker. Our durable, rugged ... make every day use even easier. This advanced ... to 4 different programs. Its easy recall function ... the VSOS-4P has a pulse operation for a ...
... Sartolab P20 and Sartolab P20 plus,for ... Ready-to-use units which, attached to a,membrane pump ... ml to 5 liter of media,and aqueous ... filtration area,(20 cm2) and an automatic de-aeration,ensures ...
... Validation Service enables early selection of ... by providing quantitative data for sensitivity, ... each antibody. Furthermore quantitative antibody fingerprints ... activity of your antibodies., The full-service ...
... is a fluorescent microscopy-based imaging system that ... and automatically calculates cell viability, in a ... function, the variability associated with the subjective ... Using the EasyCount ViaSure Kit, up to ...
Biology Products: